ArticleBMJ public health2026

Guiding vaccine policy for chikungunya in Brazil: a cost-effectiveness analysis of live-attenuated versus recombinant chikungunya vaccines in Brazilian adults ≥18 years.

Christina Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.